The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Global spread of carbapenem-resistant Acinetobacter baumannii
Higgins, P. G., Dammhayn, C., Hackel, M., & Seifert, H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp428 · Cited by 607
Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates
Jawad, A., Seifert, H., Snelling, A. M., Heritage, J., & Hawkey, P. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1938-1941.1998 · Cited by 464
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
Souli, M., Galani, I., & Giamarellou, H. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19045-en · Cited by 436
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Worldwide Dissemination of the blaOXA-23Carbapenemase Gene of Acinetobacter baumannii 1
Mugnier, P. D., Poirel, L., Naas, T., & Nordmann, P. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1601.090852 · Cited by 431
Acinetobacter Outbreaks, 1977–2000
Villegas, M. V., & Hartstein, A. I. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502205 · Cited by 402
Survival of Acinetobacter baumannii on dry surfaces
Wendt, C., Dietze, B., Dietz, E., & Rüden, H. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1394-1397.1997 · Cited by 400
Falagas, M. E., Koletsi, P. K., & Bliziotis, I. A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46747-0 · Cited by 399
Lockhart, S. R., Abramson, M. A., Beekmann, S. E., Gallagher, G., Riedel, S., Diekema, D. J., Quinn, J. P., & Doern, G. V. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01284-07 · Cited by 396
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Treatment of Acinetobacter Infections
Fishbain, J., & Peleg, A. Y. (2010) · Clinical Infectious Diseases · doi:10.1086/653120 · Cited by 358
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou, V., Cornaglia, G., Edelstein, M., Galani, I., Giske, C. G., Gniadkowski, M., Malamou-Lada, E., Martinez-Martinez, L., Navarro, F., Nordmann, P., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03116.x · Cited by 350
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Seifert, H., Dijkshoorn, L., Gerner-Smidt, P., Pelzer, N., Tjernberg, I., & Vaneechoutte, M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2819-2825.1997 · Cited by 322
Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
Vallenet, D., Nordmann, P., Barbe, V., Poirel, L., Mangenot, S., Bataille, E., Dossat, C., Gas, S., Kreimeyer, A., Lenoble, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001805 · Cited by 314
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Infectious Complications of Open Type III Tibial Fractures among Combat Casualties
Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R., & Murray, C. K. (2007) · Clinical Infectious Diseases · doi:10.1086/520029 · Cited by 276
Falagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Emergence of NDM-1-producing Acinetobacter baumannii in China
Chen, Y., Zhou, Z., Jiang, Y., & Yu, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr082 · Cited by 271
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Karthikeyan, K., Thirunarayan, M. A., & Krishnan, P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq273 · Cited by 243
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?
Rolain, J. M., Parola, P., & Cornaglia, G. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03385.x · Cited by 238
Self-citationPoirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Donald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt
Kaase, M., Nordmann, P., Wichelhaus, T. A., Gatermann, S. G., Bonnin, R. A., & Poirel, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr135 · Cited by 231
Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., & Samonis, G. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207
Moffatt, J. H., Harper, M., Adler, B., Nation, R. L., Li, J., & Boyce, J. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01732-10 · Cited by 196
Post, V., White, P. A., & Hall, R. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq095 · Cited by 178
Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C., & Boucher, B. A. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 174
Distribution of Acinetobacter Species on Skin of Healthy Humans
Aucken, H., Berlau, J., Malnick, H., & Pitt, T. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050254 · Cited by 166
Garnacho, J., Sole-Violan, J., Sa-Borges, M., Diaz, E., & Rello, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089936.09573.f3 · Cited by 159
Genetic support of extended-spectrum β-lactamases
Poirel, L., Naas, T., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01865.x · Cited by 153
Seasonal Variation of Acinetobacter Infections: 1987-1996
McDonald, L. C., Banerjee, S. N., Jarvis, W. R., & System, N. N. I. S. (1999) · Clinical Infectious Diseases · doi:10.1086/313441 · Cited by 145
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
Conway, S. P., Brownlee, K. G., Denton, M., & Peckham, D. G. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256660 · Cited by 142
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii
López-Rojas, R., Domínguez-Herrera, J., McConnell, M. J., Docobo-Pérez, F., Smani, Y., Fernández‐Reyes, M., Rivas, L., & Pachón, J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq086 · Cited by 141
Hospital-acquired infections following the 1999 Marmara earthquake
Öncül, O., Keskin, Ö., Hakan Volkan, A. C. A. R., Küçükardalı, Y., Evrenkaya, R., Atasoyu, E. M., Top, C., Nalbant, S., Özkan, S., Emekdaş, G., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1205 · Cited by 136
Wareham, D. W., Bean, D. C., Khanna, P., Hennessy, E., Krahé, D., Ely, A., & Millar, M. R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0473-y · Cited by 123
Hornsey, M., Loman, N. J., Wareham, D. W., Ellington, M. J., Pallen, M. J., Turton, J. F., Underwood, A. P., Gaulton, T., Thomas, C. P., Doumith, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr168 · Cited by 123
VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1208.051547 · Cited by 122
New insights into the antibacterial mechanism of action of squalamine
Alhanout, K., Malesinki, S., Vidal, N., Peyrot, V., Rolain, J., & Brunel, J. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq213 · Cited by 117
Self-citationRodríguez, C. H., Bombicino, K. A., Granados, G., Nastro, M., Carlos, V., & Angela, F. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.05.019 · Cited by 116
Erridge, C., Moncayo-Nieto, O. L., Morgan, R., Young, M., & Poxton, I. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46823-0 · Cited by 112
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1708.051547 · Cited by 110
Kohlenberg, A., Brümmer, S., Higgins, P. G., Sohr, D., Piening, B., de Grahl, C., Halle, E., Rüden, H., & Seifert, H. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.012302-0 · Cited by 107
D’Arezzo, S., Principe, L., Capone, A., Petrosillo, N., Petrucca, A., & Visca, P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq407 · Cited by 83
Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea
Park, Y. K., Jung, S.-I., Park, K. H., Cheong, H. S., Peck, K. R., Song, J., & Ko, K. S. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.01.012 · Cited by 82
Consales, G., Gramigni, E., Zamidei, L., Bettocchi, D., & Gaudio, A. R. D. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.12.016 · Cited by 68
Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors
Tao, C., Kang, M., Chen, Z., Xie, Y., Fan, H. S., Li, Q., & Ma, Y. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.009 · Cited by 56
Kusradze, I., Diene, S. M., Goderdzishvili, M., & Rolain, J. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.03.021 · Cited by 55
Self-citationComparative activity of carbapenem testing: the COMPACT study
Nordmann, P., Picazo, J. J., Mutters, R., Korten, V., Quintana, A., Laeuffer, J., Seak, J. C. H., Flamm, R. K., Morrissey, I., on behalf of the COMPACT study group, et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr056 · Cited by 53
Mantengoli, E., & Rossolini, G. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3289-3296.2005 · Cited by 53
Rodloff, A. C., Leclercq, R., Debbia, E. A., Cantón, R., Oppenheim, B. A., & Dowzicky, M. J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01943.x · Cited by 44
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Szabó, D., Szentandrássy, J., Juhasz, Z., Katona, K., Nagy, K., & Rókusz, L. (2008) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-7-12 · Cited by 41
Study Group, Kresken, M., Becker, K., Seifert, H., Leitner, E., Körber-Irrgang, B., von Eiff, C., & Löschmann, P. A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1197-y · Cited by 30
Cited by
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
Ellington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Self-citationColistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Self-citationMechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Resistance to polymyxins in Gram-negative organisms
Jeannot, K., Bolard, A., & Plésiat, P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.029 · Cited by 402
Metadata
- Authors
- Kempf, M., & Rolain, J.-M.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 39
- Issue
- 2
- Pages
- 105-114
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2060413674
- Cited by
- 389
- References
- 72
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.